Want to better understand COVID-19 and how doctors care for patients in hospital? Join this webinar to hear from two clinical experts at Imperial College London who are at the forefront of research and patient care during the COVID-19 pandemic.
Imperial College Academic Health Science Centre (AHSC) is working at the forefront of research and patient care during the COVID-19 pandemic. As part of our AHSC COVID-19 webinar series, two experts will talk about their research to better understand COVID-19 and how to treat it. This online seminar will be live and open to all.
Professor Peter Openshaw, from Imperial College London’s National Heart and Lung Institute, is a Professor of Experimental Medicine and an Honorary Physician at Imperial College Healthcare NHS Trust. He is one of three researchers leading Europe’s largest study analysing samples from COVID-19 patients to learn more about the disease and how it progresses.
The UK-wide study is called the International Severe Acute Respiratory Infection Consortium (ISARIC 4C) study. Researchers are collecting blood samples and clinical data from COVID-19 patients in hospitals across the UK including St Mary’s and Charing Cross Hospitals, part of Imperial College Healthcare NHS Trust.
Preliminary analysis confirms that high blood pressure, coronary heart disease, obesity and chronic lung disease are risk factors that can lead to severe cases of COVID-19.
As they continue to collect samples, the team hope to uncover more about who is at higher risk of severe illness and why, what is the best way to diagnose the disease, what effects treatments have and what role the immune system plays in protecting the body and, potentially, in causing harm.
Professor Openshaw will be joined by Dr Brijesh Patel, Clinical Senior Lecturer at Imperial College London and Honorary Consultant at Royal Brompton & Harefield NHS Foundation Trust. He is leading a trial to test a new AI device to help monitor the lung physiology of patient’s with severe COVID-19 pneumonia; the DeVENT trial.
Patients with severe symptoms of COVID-19 may develop a condition known as Acute Respiratory Distress Syndrome (ARDS) - a life-threatening condition where the lungs cannot provide the body’s vital organs with enough oxygen. Patients who develop ARDS require mechanical ventilation which takes over their breathing.
Mechanical ventilation delivers a volume and pressure of gas for each breath and can vary oxygen levels. Selecting the correct oxygen, pressure and volume settings is vital, as incorrect settings can harm the patient, and lengthen the time patients spend connected to the ventilator. If the patient’s oxygen levels remain low despite mechanical ventilation, they may be placed on an artificial lung machine called extracorporeal membrane oxygenation (or ECMO), a service delivered by the Royal Brompton Hospital.
The DeVENT trial will test a new device called the Beacon Caresystem which is connected to a ventilator and advises the healthcare staff on which ventilator settings to use based on continuous monitoring and complex mathematics.
In addition, to understanding the severe physiology of these patients with this device, the DeVENT study is also collecting samples and images of patients lungs with the hope to understanding new mechanisms of lung failure.
Wednesday 1 July 2020
Online event - you will receive a link to join the online event after registering via Eventbrite.